Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
End Relative To Reference Code	NCIT_C93561	[A coded value specifying when an event ended with respect to the sponsor-defined reference period.]
Recurrent Adult Liver Carcinoma	NCIT_C7880	[A hepatocellular carcinoma or intrahepatic cholangiocarcinoma that occurs during adulthood and has recurred after a period of remission.]
Performed Substance Administration Period Dose Total	NCIT_C93976	[The total of all doses of treatment in a given period of time (as defined in dosePeriodCode).]
Period Dose Total	NCIT_C93620	[Total of all doses of treatment in a given period of time.]
Recurrent Osteosarcoma	NCIT_C7881	[The reemergence of osteosarcoma after a period of remission.]
Osteosarcoma	NCIT_C9145	[A usually aggressive malignant bone-forming mesenchymal neoplasm, predominantly affecting adolescents and young adults. It usually involves bones and less frequently extraosseous sites. It often involves the long bones (particularly distal femur, proximal tibia, and proximal humerus). Pain with or without a palpable mass is the most frequent clinical symptom. It may spread to other anatomic sites, particularly the lungs.]
Recurrent Sarcoma	NCIT_C148302	[The reemergence of sarcoma after a period of remission.]
Performed Substance Administration Planned Change Indicator	NCIT_C93977	[Specifies whether a change in the substance administration in relation to the previous substance administration is planned or not.]
Planned Change Indicator	NCIT_C93624	[Specifies whether a change in an activity, event or entity is planned or not.]
Recurrent Adult Acute Myeloid Leukemia	NCIT_C7882	[The reemergence of acute myeloid leukemia in adults after a period of remission.]
Recurrent Acute Myeloid Leukemia	NCIT_C148427	[The reemergence of acute myeloid leukemia after a period of remission.]
Performed Substance Administration Route Of Administration Code	NCIT_C93978	[A coded value specifying the physiological path or method of introducing the substance into or onto the subject.]
Route Of Administration Code	NCIT_C93667	[A coded value specifying the designation of the part of the body through which, into which, or the way in which the medicinal product is intended to be introduced.]
Performed Substance Administration Start Relative To Reference Code	NCIT_C93979	[A coded value specifying when this event started with respect to the sponsor-defined reference period.]
Start Relative To Reference Code	NCIT_C93673	[A coded value specifying when this event started with respect to the sponsor-defined reference period.]
Stage III Bladder Cancer AJCC v6 and v7	NCIT_C7898	[Stage III includes: (T3a, N0, M0); (T3b, N0, M0); (T4a, N0, M0). T3a: Tumor microscopically invades perivesical tissue. T3b: Tumor macroscopically invades perivesical tissue (extravesical mass). T4a: Tumor invades prostatic stroma, uterus, vagina. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)]
Bladder Cancer by AJCC v6 Stage	NCIT_C90344	[A term that refers to the staging of bladder cancer according to the American Joint Committee on Cancer, 6th edition.]
Bladder Cancer by AJCC v7 Stage	NCIT_C91202	[A term that refers to the staging of bladder cancer according to the American Joint Committee on Cancer, 7th edition.]
Recurrent Urinary System Carcinoma	NCIT_C7623	[Reemergence of a urinary system carcinoma after a period of remission.]
Recurrent Malignant Bladder Neoplasm	NCIT_C9266	[The reemergence of a malignant bladder neoplasm after a period of remission.]